204
Views
10
CrossRef citations to date
0
Altmetric
Research Article

Nationwide Trends in the Incidence and Survival of Eyelid Skin Cancers in Korea

, , , &
Pages 438-448 | Received 28 Feb 2020, Accepted 05 May 2020, Published online: 02 Jun 2020

References

  • Kleinstein RN, Lehman HF. Incidence and prevalence of eye cancer. Am J Optom Physiol Opt. 1977;54:49–51. doi:10.1097/00006324-197701000-00008.
  • Domonkos AN. Treatment of eyelid carcinoma. Arch Dermatol. 1965;91:364–371. doi:10.1001/archderm.1965.01600100080023.
  • Bernardini FP. Management of malignant and benign eyelid lesions. Curr Opin Ophthalmol. 2006;17:480–484. doi:10.1097/01.icu.0000243022.20499.90.
  • Donaldson MJ, Sullivan TJ, Whitehead KJ, Williamson RM. Squamous cell carcinoma of the eyelids. Br J Ophthalmol. 2002;86:1161–1165. doi:10.1136/bjo.86.10.1161.
  • Tesluk GC. Eyelid lesions: incidence and comparison of benign and malignant lesions. Ann Ophthalmol. 1985;17:704–707.
  • Margo CE, Waltz K. Basal cell carcinoma of the eyelid and periocular skin. Surv Ophthalmol. 1993;38:169–192. doi:10.1016/0039-6257(93)90100-L.
  • Ni C, Searl SS, Kuo PK, Chu FR, Chong CS, Albert DM. Sebaceous cell carcinomas of the ocular adnexa. Int Ophthalmol Clin. 1982;22:23–61. doi:10.1097/00004397-198202210-00006.
  • Kim GK, Del Rosso JQ, Bellew S. Skin cancer in asians: part 1: nonmelanoma skin cancer. J Clin Aesthet Dermatol. 2009;2:39–42.
  • Wang JK, Liao SL, Jou JR, et al. Malignant eyelid tumours in Taiwan. Eye (Lond). 2003;17:216–220. doi:10.1038/sj.eye.6700231.
  • Cook BE Jr., Bartley GB. Epidemiologic characteristics and clinical course of patients with malignant eyelid tumors in an incidence cohort in Olmsted County, Minnesota. Ophthalmology. 1999;106:746–750. doi:10.1016/S0161-6420(99)90161-6.
  • Lin HY, Cheng CY, Hsu WM, Kao WH, Chou P. Incidence of eyelid cancers in Taiwan: a 21-year review. Ophthalmology. 2006;113:2101–2107. doi:10.1016/j.ophtha.2006.06.001.
  • Wawrzynski J, Tudge I, Fitzgerald E, et al. Report on the incidence of squamous cell carcinomas affecting the eyelids in England over a 15-year period (2000–2014). Br J Ophthalmol. 2018;102:1358–1361. doi:10.1136/bjophthalmol-2017-310956.
  • Lim VS, Amrith S. Declining incidence of eyelid cancers in Singapore over 13 years: population-based data from 1996 to 2008. Br J Ophthalmol. 2012;96:1462–1465. doi:10.1136/bjophthalmol-2012-302032.
  • Saleh GM, Desai P, Collin JR, Ives A, Jones T, Hussain B. Incidence of eyelid basal cell carcinoma in England: 2000–2010. Br J Ophthalmol. 2017;101:209–212. doi:10.1136/bjophthalmol-2015-308261.
  • Lee SB, Saw SM, Au Eong KG, Chan TK, Lee HP. Incidence of eyelid cancers in Singapore from 1968 to 1995. Br J Ophthalmol. 1999;83:595–597. doi:10.1136/bjo.83.5.595.
  • Oh CM, Won YJ, Jung KW, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2013. Cancer Res Treat. 2016;48:436–450. doi:10.4143/crt.2016.089.
  • Howlader N, Noone AM, Krapcho M, et al. SEER Cancer Statistics Review, 1975–2010. Bethesda, MD: National Cancer Institute; 2013: based on November 2012 SEER data submission, posted to the SEER web site.
  • Young JL Jr, Roffers SD, Ries LAG, Fritz AG, Hurlbut AA, (eds.). SEER Summary Staging Manual - 2000: Codes and Coding Instructions. Bethesda, MD: National Caner Institute, NIH Pub.; 2001.
  • Brenner H, Gefeller O. Deriving more up-to-date estimates of long-term patient survival. J Clin Epidemiol. 1997;50:211–216. doi:10.1016/S0895-4356(97)00280-1.
  • Ederer F, Heise H. Instructions to IBM 650 programmers in processing survival computations. Methodological note, No.10. Bethesda, MD: National Cancer Institute; 1959.
  • Youn JI, Choe YB, Park SB, et al. The Fitzpatrick skin type in Korean people. Korean J Dermatol. 2000;38:920–927.
  • Thun M, Linet MS, Cerhan R, Haiman CA, Schottenfeld D, (eds.). Cancer Epidemiology and Prevention. 4th ed. London: Oxford University Press; 2018.
  • Anders MP, Nolte S, Waldmann A, et al. The German SCREEN project–design and evaluation of the communication strategy. Eur J Public Health. 2015;25:150–155. doi:10.1093/eurpub/cku047.
  • de Vries E, Louwman M, Bastiaens M, de Gruijl F, Coebergh JW. Rapid and continuous increases in incidence rates of basal cell carcinoma in the southeast Netherlands since 1973. J Invest Dermatol. 2004;123:634–638. doi:10.1111/j.0022-202X.2004.23306.x.
  • Paavilainen V, Tuominen J, Pukkala E, Saari KM. Basal cell carcinoma of the eyelid in Finland during 1953–97. Acta Ophthalmol Scand. 2005;83:215–220. doi:10.1111/j.1600-0420.2005.00445.x.
  • Kaldor J, Shugg D, Young B, Dwyer T, Wang YG. Non-melanoma skin cancer: ten years of cancer-registry-based surveillance. Int J Cancer. 1993;53:886–891. doi:10.1002/ijc.2910530603.
  • Koh D, Wang H, Lee J, Chia KS, Lee HP, Goh CL. Basal cell carcinoma, squamous cell carcinoma and melanoma of the skin: analysis of the Singapore cancer registry data 1968–97. Br J Dermatol. 2003;148:1161–1166. doi:10.1046/j.1365-2133.2003.05223.x.
  • Gilbody JS, Aitken J, Green A. What causes basal cell carcinoma to be the commonest cancer? Aust J Public Health. 1994;18:218–221. doi:10.1111/j.1753-6405.1994.tb00231.x.
  • Xiang F, Lucas R, Hales S, Neale R. Incidence of nonmelanoma skin cancer in relation to ambient UV radiation in white populations, 1978–2012: empirical relationships. JAMA Dermatol. 2014;150:1063–1071. doi:10.1001/jamadermatol.2014.762.
  • Sng J, Koh D, Siong WC, Choo TB. Skin cancer trends among Asians living in Singapore from 1968 to 2006. J Am Acad Dermatol. 2009;61:426–432. doi:10.1016/j.jaad.2009.03.031.
  • Kass LG, Hornblass A. Sebaceous carcinoma of the ocular adnexa. Surv Ophthalmol. 1989;33:477–490. doi:10.1016/0039-6257(89)90049-0.
  • Kaliki S, Bothra N, Bejjanki KM, et al. Malignant eyelid tumors in India: a study of 536 Asian Indian patients. Ocul Oncol Pathol. 2019;5:210–219. doi:10.1159/000491549.
  • Ni Z. Histopathological classification of 3,510 cases with eyelid tumor. Zhonghua Yan Ke Za Zhi. 1996;32:435–437.
  • Mak ST, Wong AC, Io IY, Tse RK. Malignant eyelid tumors in Hong Kong 1997–2009. Jpn J Ophthalmol. 2011;55:681–685. doi:10.1007/s10384-011-0077-4.
  • Makredes M, Hui SK, Kimball AB. Melanoma in Hong Kong between 1983 and 2002: a decreasing trend in incidence observed in a complex socio-political and economic setting. Melanoma Res. 2010;20:427–430. doi:10.1097/CMR.0b013e3283281072.
  • Wassberg C, Thorn M, Johansson AM, Bergstrom R, Berne B, Ringborg U. Increasing incidence rates of squamous cell carcinoma of the skin in Sweden. Acta Derm Venereol. 2001;81:268–272. doi:10.1080/00015550152572903.
  • Jemal A, Devesa SS, Hartge P, Tucker MA. Recent trends in cutaneous melanoma incidence among whites in the United States. J Natl Cancer Inst. 2001;93:678–683. doi:10.1093/jnci/93.9.678.
  • Boulos PR, Rubin PA. Cutaneous melanomas of the eyelid. Semin Ophthalmol. 2006;21:195–206. doi:10.1080/08820530500353864.
  • Vaziri M, Buffam FV, Martinka M, Oryschak A, Dhaliwal H, White VA. Clinicopathologic features and behavior of cutaneous eyelid melanoma. Ophthalmology. 2002;109:901–908. doi:10.1016/S0161-6420(02)00962-4.
  • Esmaeli B, Youssef A, Naderi A, et al. Margins of excision for cutaneous melanoma of the eyelid skin: the collaborative eyelid skin melanoma group report. Ophthalmic Plast Reconstr Surg. 2003;19:96–101. doi:10.1097/01.IOP.0000056141.97930.E8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.